Approval · Notice of Compliance 37735 · 2026
BOEY: Notice of Compliance 37735
Issued June 22, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 37735
- Date
- June 22, 2026
- Company
- AbbVie CorporationSaint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BOEY | 02569086 | Approved |
Medicinal ingredients
- TRENIBOTULINUMTOXINE 1,400 UNIT per VIAL